Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease
Latest Publications

TOTAL DOCUMENTS

(FIVE YEARS 17)

H-INDEX

(FIVE YEARS 0)

Published By Elsevier

9780128205365

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

A look into the future

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00006-9 ◽

2021 ◽

pp. 201-202

Author(s):

Sorin J. Brener

Keyword(s):

The Future

Preface

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.05001-1 ◽

2021 ◽

pp. xiii

Platelet physiology and pharmacology—relevant considerations for patient care

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00005-7 ◽

2021 ◽

pp. 15-45

Author(s):

Chang Hoon Lee ◽

Dominick J. Angiolillo

Keyword(s):

Patient Care ◽

Platelet Physiology

Competing risks in the duration of dual antiplatelet therapy—the case for shorter treatment

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00001-x ◽

2021 ◽

pp. 111-130

Author(s):

Francesco Costa ◽

Marco Valgimigli

Keyword(s):

Antiplatelet Therapy ◽

Competing Risks ◽

Dual Antiplatelet Therapy

Peripheral arterial disease—a different kind of arterial disease? The role of antiplatelet therapy in the prevention and treatment of limb ischemia

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00003-3 ◽

2021 ◽

pp. 79-89

Author(s):

Sudhakar Sattur

Keyword(s):

Peripheral Arterial Disease ◽

Antiplatelet Therapy ◽

Limb Ischemia ◽

Arterial Disease ◽

Prevention And Treatment ◽

Peripheral Arterial

Copyright

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.12001-4 ◽

2021 ◽

pp. iv

Clinical risk scores: a tool to understand bleeding and thrombotic risk

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00010-0 ◽

2021 ◽

pp. 145-166

Author(s):

Robert Yeh ◽

Nino Mihatov

Keyword(s):

Risk Scores ◽

Thrombotic Risk ◽

Clinical Risk

The development of dual antiplatelet therapy: physiologic and clinical implications of multiple pathway inhibition of platelet function

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00011-2 ◽

2021 ◽

pp. 47-56

Author(s):

Adam T. Phillips ◽

C. Michael Gibson

Keyword(s):

Antiplatelet Therapy ◽

Platelet Function ◽

Dual Antiplatelet Therapy ◽

Clinical Implications ◽

Multiple Pathway ◽

Pathway Inhibition

Acute coronary syndromes and percutaneous coronary intervention—current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00002-1 ◽

2021 ◽

pp. 57-77

Author(s):

Lauren S. Ranard ◽

Sorin J. Brener

Keyword(s):

Percutaneous Coronary Intervention ◽

Antiplatelet Therapy ◽

Acute Coronary Syndromes ◽

Dual Antiplatelet Therapy ◽

Coronary Intervention ◽

Percutaneous Coronary ◽

Coronary Syndromes

The conundrum of simultaneous antiplatelet and anticoagulant therapy: how to solve it?

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease ◽

10.1016/b978-0-12-820536-5.00012-4 ◽

2021 ◽

pp. 193-199

Author(s):

Freek W.A. Verheugt ◽

Robert F. Storey

Keyword(s):

Anticoagulant Therapy

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial DiseaseLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

A look into the future

Preface

Platelet physiology and pharmacology—relevant considerations for patient care

Competing risks in the duration of dual antiplatelet therapy—the case for shorter treatment

Peripheral arterial disease—a different kind of arterial disease? The role of antiplatelet therapy in the prevention and treatment of limb ischemia

Copyright

Clinical risk scores: a tool to understand bleeding and thrombotic risk

The development of dual antiplatelet therapy: physiologic and clinical implications of multiple pathway inhibition of platelet function

Acute coronary syndromes and percutaneous coronary intervention—current recommendations for dual antiplatelet therapy. Are guidelines reflecting the data?

The conundrum of simultaneous antiplatelet and anticoagulant therapy: how to solve it?

Dual Antiplatelet Therapy for Coronary and Peripheral Arterial Disease
Latest Publications